Lujing Wang

Lujing joined OPEN Health in 2023 with Acsel Health. He brings broad experience in both public and private sectors in the areas of healthcare financing, health policy and system research, and pricing and market access consulting. He has assisted many leading pharmaceutical and biotech companies in developing pricing and market access, evidence generation, and new product commercialization strategies across therapeutic areas. Offering deep expertise and trusted multidisciplinary experience, he works closely with his teams and clients to identify transformative opportunities and actional insights in constantly evolving markets.